PI3K functions in cancer progression, anticancer immunity and immune evasion by tumors.
about
The effect of chemotherapy on programmed cell death 1/programmed cell death 1 ligand axis: some chemotherapeutical drugs may finally work through immune responseSustained proliferation in cancer: Mechanisms and novel therapeutic targetsDetection of rapalog-mediated therapeutic response in renal cancer xenografts using ⁶⁴Cu-bevacizumab immunoPETPI3K p110γ deletion attenuates murine atherosclerosis by reducing macrophage proliferation but not polarization or apoptosis in lesions.hrHPV E5 oncoprotein: immune evasion and related immunotherapies.Induction of ATM/ATR pathway combined with Vγ2Vδ2 T cells enhances cytotoxicity of ovarian cancer cellsFascin is involved in the chemotherapeutic resistance of breast cancer cells predominantly via the PI3K/Akt pathwayIdentification of a role for the PI3K/AKT/mTOR signaling pathway in innate immune cellsStratification of clear cell renal cell carcinoma (ccRCC) genomes by gene-directed copy number alteration (CNA) analysisRhodomycin A, a novel Src-targeted compound, can suppress lung cancer cell progression via modulating Src-related pathways.Stalling the engine of resistance: targeting cancer metabolism to overcome therapeutic resistance.Somatic mutation profiling and associations with prognosis and trastuzumab benefit in early breast cancerCancer Stem Cells and Their Microenvironment: Biology and Therapeutic Implications.Phosphorylation of PRAS40-Thr246 involved in renal lipid accumulation of diabetes.Inhibition of Phosphorylated c-Jun NH(2)-terminal Kinase by 2',4'-dihydroxy-6-methoxy-3,5-dimethylchalcone Isolated from Eugenia aquea Burm f. Leaves in Jurkat T-cells.Oncosuppressors and Oncogenes: Role in Haemangioma Genesis and Potential for Therapeutic Targeting.
P2860
Q26766066-7FB83D09-F6BA-43C3-8AB4-D0A8D6421FBFQ28396388-4B7D1FBA-5091-4432-83E4-478F82B489C4Q28487987-8E3643B4-AA4D-4D12-884C-0ACA6E2D57D6Q31133175-0534E0E4-152D-4A0E-9718-FA89C11FF0DAQ33730462-5E58A92F-2C19-4732-A08C-735CCD386BABQ33849537-39F7F90C-A6B5-4E19-9E8E-D3B676BBF317Q34354577-BA4B0B1F-C9C3-4AF1-8FC1-C40FEC20EA9DQ35144129-6B224BD7-B575-4B9B-B073-8B75558B101CQ36367103-05C16396-3A89-49AE-A124-8BB1ADAB327EQ36413425-0B03A444-E7B0-4CCC-8522-ADC9FDFA43CBQ36815271-323707A2-13FB-47AB-BDA1-FDEA7C2742B6Q36976208-E13A81C2-C9AD-4DB5-A9D3-338981A92272Q39197682-2CE01BCF-9A94-44FC-8AE1-5A9B9F5AB460Q46708537-56DC733F-1BE8-45BE-88F2-98098B3B55DCQ47137756-4048755F-D65D-4B75-A356-2C1B719A5FD7Q53693166-F623A71F-42B0-4F8A-9AEC-A4AC98E7F8E9
P2860
PI3K functions in cancer progression, anticancer immunity and immune evasion by tumors.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
PI3K functions in cancer progression, anticancer immunity and immune evasion by tumors.
@en
PI3K functions in cancer progression, anticancer immunity and immune evasion by tumors.
@nl
type
label
PI3K functions in cancer progression, anticancer immunity and immune evasion by tumors.
@en
PI3K functions in cancer progression, anticancer immunity and immune evasion by tumors.
@nl
prefLabel
PI3K functions in cancer progression, anticancer immunity and immune evasion by tumors.
@en
PI3K functions in cancer progression, anticancer immunity and immune evasion by tumors.
@nl
P2860
P356
P1476
PI3K functions in cancer progression, anticancer immunity and immune evasion by tumors
@en
P2093
Francesco Dituri
Salvatore Antonaci
P2860
P304
P356
10.1155/2011/947858
P5008
P577
2011-10-20T00:00:00Z